FAKTOR OPTIONSSCHEIN - STRYKER CORP. Stock

Certificat

DE000PG10YK8

Market Closed - Deutsche Boerse AG 03:50:38 2024-06-20 pm EDT
30.68 EUR -26.21% Intraday chart for FAKTOR OPTIONSSCHEIN - STRYKER CORP.
Current month+33.44%
1 month+39.02%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-20 30.68 -26.21%
24-06-19 41.58 +5.43%
24-06-18 39.44 +13.01%
24-06-17 34.9 -0.34%
24-06-14 35.02 +2.43%

Delayed Quote Deutsche Boerse AG

Last update June 20, 2024 at 03:50 pm EDT

More quotes

Static data

Product typeExotische Produkte
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PG10YK
ISINDE000PG10YK8
Date issued 2023-03-22
Strike 348.7 $
Maturity Unlimited
Parity 1 : 1
Emission price 100
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 218.5
Lowest since issue 6.03
Spread 1.33
Spread %4.11%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
348.7 USD
Average target price
372.9 USD
Spread / Average Target
+6.96%
Consensus